Hyperfine, Inc.
HYPR- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001833769
In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.
Holders of 5% or more of HYPR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Hyperfine, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Hyperfine, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Hyperfine, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 30, 20262:18 PM ET | Vanguard Group Inc | 13G/A | 4.34%3.57M shares | –Below 5% | Dec 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Hyperfine, Inc. shares.
No Form 144 notices for Hyperfine, Inc. are on file.